Revolutionize clinical oversight with intelligent, ethical, and compliant AI automation.
Empower sponsors, CROs, and clinical teams with AI that improves data accuracy, reduces manual workload, and ensures compliance.
Myster Peasah is the Founder and CEO of CRA-IQ Ltd, bringing over 18 years of experience in clinical operations within CRO and pharmaceutical environments.He has led global Phase I-III studies, Specialising in patient recruitment, site engagement, regulatory compliance, and cross-functional project leadership.Driven by a passion for innovation, Myster established CRA-IQ to harness Al-driven tools that enhance CRA performance, oversight, and data integrity in clinical research.His mission is to bridge human expertise with intelligent automation to make drug development faster, safer, and more efficient.
Emeka Maddy is the Chief Technology Officer of CRA-IQ Ltd, bringing over 10 years of experience across the clinical research spectrum from site monitoring and central lab operations to project management and product innovation.
With a career spanning role as a Senior Clinical Research Associate, PMO Specialist, and Product Manager, Emeka has led initiatives that transformed operational efficiency and data integrity in global clinical trials. His leadership has delivered measurable impact, including automation projects that saved thousands of hours per month, advanced API integrations, and AI/ML-driven solutions projected to save millions in operational costs.
At CRA-IQ, Emeka drives the company’s technology vision, leveraging his expertise in automation, Al adoption, and digital product management to build intelligent platforms that empower CRAs, streamline oversight, and enhance regulatory compliance. Guided by a passion for innovation, his mission is to bridge clinical expertise with cutting-edge technology making drug development smarter, faster, and more resilient.
Transforming Clinical Monitoring with Measurable Impact
CRA-IQ Solution: AI translation engine
Result : Faster site response times
CRA-IQ is built for trust and compliance with:
Human-in-the-loop oversight ensures CRAs remain accountable for all final documentation outputs.
Regular validation, version control, and security protocols ensure inspection readiness and auditability.
– Combines human insight with machine precision.
– Reduces operational burden while maintaining regulatory trust.
– Scales efficiently across multi-phase, multi-country studies.
Frequently Asked Questions
CRA-IQ’s algorithms are trained on validated clinical datasets and reviewed by qualified CRAs.
Each AI-generated report maintains over 95% accuracy, with final human verification ensuring complete regulatory compliance.
No. CRA-IQ is designed as an AI co-pilot, not a replacement.
It automates repetitive monitoring tasks such as SDV summaries and MVR drafts, while CRAs retain full control and accountability over all final outputs.
Yes. CRA-IQ is built to align with:
FDA 21 CFR Part 11
ICH-GCP E6(R2/R3)
EU AI Act
GDPR & HIPAA
This ensures that all documentation is audit-ready and inspection-compliant.
Absolutely. CRA-IQ integrates with major platforms as well as EDC, CTMS, and eTMF environments through secure API connections.
CRA-IQ supports multilingual documentation — including English, Spanish, French, German, and Japanese — helping global teams manage multi-country studies without translation delays.
Our team is ready to assist you with expert support and quick answers for any challenge you are facing today.
